Title |
Emerging markers of cachexia predict survival in cancer patients
|
---|---|
Published in |
BMC Cancer, November 2014
|
DOI | 10.1186/1471-2407-14-828 |
Pubmed ID | |
Authors |
Patrizia Mondello, Antonio Lacquaniti, Stefania Mondello, Davide Bolignano, Vincenzo Pitini, Carmela Aloisi, Michele Buemi |
Abstract |
Cachexia may occur in 40% of cancer patients, representing the major cause of death in more than 20% of them. The aim of this study was to investigate the role of leptin, ghrelin and obestatin as diagnostic and predictive markers of cachexia in oncologic patients. Their impact on patient survival was also evaluated. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 100 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 16 | 16% |
Student > Ph. D. Student | 15 | 15% |
Researcher | 13 | 13% |
Student > Master | 12 | 12% |
Student > Doctoral Student | 10 | 10% |
Other | 18 | 18% |
Unknown | 16 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 35 | 35% |
Nursing and Health Professions | 11 | 11% |
Agricultural and Biological Sciences | 10 | 10% |
Biochemistry, Genetics and Molecular Biology | 8 | 8% |
Chemistry | 3 | 3% |
Other | 10 | 10% |
Unknown | 23 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2014.
All research outputs
#18,383,471
of 22,770,070 outputs
Outputs from BMC Cancer
#5,416
of 8,280 outputs
Outputs of similar age
#165,849
of 231,966 outputs
Outputs of similar age from BMC Cancer
#124
of 181 outputs
Altmetric has tracked 22,770,070 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,280 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 231,966 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 181 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.